ArticleEnvironmental science & technology2022
Thirdhand Exposures to Tobacco-Specific Nitrosamines through Inhalation, Dust Ingestion, Dermal Uptake, and Epidermal Chemistry.
Open access · greenAbstract read
In one paragraph
Article in Environmental science & technology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 31 citations in OpenAlex.
- On the Detection and Scope of "Third-Hand Vaping": A Critical Review of the Literature.International journal of environmental research and public health · 2026Review
- Quantitative reference levels for thirdhand smoke residue from tobacco products in indoor environments: a systematic review and meta-analysis.Journal of exposure science & environmental epidemiology · 2026Review
- Mediation of sphingolipid metabolism on the relationship between human nitrosamines exposure and esophageal cancer risk.Scientific reports · 2026Article
- Low dose thirdhand smoke exposure enhances platelet functional responses in mice.Experimental biology and medicine (Maywood, N.J.) · 2026Article
- Thirdhand Smoke and Neonatal/Pediatric Health: A Scoping Review on Nursing Implications.Healthcare (Basel, Switzerland) · 2025Review
- Assessment, detection, and validation of clinical associations of thirdhand smoke exposure (ADVOCATE) study protocol.Pediatric research · 2025Article
- Policy-relevant differences between secondhand and thirdhand smoke: strengthening protections from involuntary exposure to tobacco smoke pollutants.Tobacco control · 2024Article
- Analytical Methodologies to Detect N-Nitrosamine Impurities in Active Pharmaceutical Ingredients, Drug Products and Other Matrices.Chemical research in toxicology · 2024Review
- Sex-Dependent Occlusive Cardiovascular Disease Effects of Short-Term Thirdhand Smoke Exposure.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2024Article
- Contamination of surfaces in children's homes with nicotine and the potent carcinogenic tobacco-specific nitrosamine NNK.Journal of exposure science & environmental epidemiology · 2024Article
- Cotton pillow samplers for assessment of thirdhand smoke in homes of smokers and nonsmokers with children.Journal of environmental exposure assessment · 2024Article
- Environmental tobacco smoke exposure in a multi-city cohort of children with asthma: Analyzing true exposure and the validity of caregiver survey.Journal of clinical and translational science · 2024Article
- Changes and stability of hand nicotine levels in children of smokers: Associations with urinary biomarkers, reported child tobacco smoke exposure, and home smoking bans.Environment international · 2023Article
- Article
- Thirdhand tobacco smoke exposure increases the genetic background-dependent risk of pan-tumor development in Collaborative Cross mice.Environment international · 2023Article
- Relationship between urinary tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) and lung function: Evidence from NHANES 2007-2012.Tobacco induced diseases · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors at 4 institutions in 1 country.
Xiaochen TangIndoor Environment Group, Lawrence Berkeley National Laboratory, Berkeley, California 94720, United States.
Neal BenowitzClinical Pharmacology Program, Division of Cardiology, Department of Medicine, University of California San Francisco, San Francisco, California 94143, United States.
Lara GundelIndoor Environment Group, Lawrence Berkeley National Laboratory, Berkeley, California 94720, United States.
Bo HangBioengineering & Biomedical Sciences Department, Biological Systems & Engineering Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, United States.
Christopher M HavelClinical Pharmacology Program, Division of Cardiology, Department of Medicine, University of California San Francisco, San Francisco, California 94143, United States.
Eunha HohSchool of Public Health, San Diego State University, San Diego, California 92182, United States.ORCID 0000-0002-4075-040X
Peyton Jacob IiiClinical Pharmacology Program, Division of Cardiology, Department of Medicine, University of California San Francisco, San Francisco, California 94143, United States.ORCID 0000-0003-3366-2775
Jian-Hua MaoBioengineering & Biomedical Sciences Department, Biological Systems & Engineering Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, United States.
Manuela Martins-GreenDepartment of Molecular, Cell and Systems Biology, University of California Riverside, Riverside, California 92506, United States.
Georg E MattDepartment of Psychology, San Diego State University, San Diego, California 92182, United States.ORCID 0000-0001-5604-4609
Penelope J E QuintanaSchool of Public Health, San Diego State University, San Diego, California 92182, United States.
Marion L RussellIndoor Environment Group, Lawrence Berkeley National Laboratory, Berkeley, California 94720, United States.
Altaf SarkerBioengineering & Biomedical Sciences Department, Biological Systems & Engineering Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, United States.
Suzaynn F SchickClinical Pharmacology Program, Division of Cardiology, Department of Medicine, University of California San Francisco, San Francisco, California 94143, United States.ORCID 0000-0001-7101-3077
Antoine M SnijdersBioengineering & Biomedical Sciences Department, Biological Systems & Engineering Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, United States.
Hugo DestaillatsIndoor Environment Group, Lawrence Berkeley National Laboratory, Berkeley, California 94720, United States.ORCID 0000-0002-2132-3816
Lawrence Berkeley National Laboratory · USUniversity of California, San Francisco · USSan Diego State University · USUniversity of California, Riverside · US
Funding
Research Support CoreP30DA012393 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JACOB, PEYTON · 1999 to 2024
$17.1MLiquid Chromatograph-Triple Quadrupole Mass SpectrometerS10RR026437 · NCRR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JACOB, PEYTON · 2010 to 2010
$448kNCRR NIH HHS S10 RR026437NIDA NIH HHS P30 DA012393
Abstract
Tobacco-specific nitrosamines (TSNAs) are emitted during smoking and form indoors by nitrosation of nicotine. Two of them,
Indexed as
NitrosaminesAnimalsCarcinogensDustEatingHumansMiceNicotianaNicotineCarcinogensDustNicotineNitrosaminesC57BL/6 micecancer riskHONOnicotineskin liquids
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.